OneCell Diagnostics is now 1Cell.Ai
OneCell Diagnostics is now 1Cell.Ai
At 1Cell.Ai, we are redefining what’s possible in cancer diagnostics by combining the power of advanced molecular science with cutting-edge AI technology. Our mission is to transform cancer care by delivering real-time, clinically actionable insights through single cell multi-omics analysis, AI-driven bioinformatics, and dynamic data platforms.
We believe that progress happens when scientific innovation meets technological excellence—and we’re dedicated to bringing this synergy to every clinician, researcher, and biopharma partner we serve.
To make precision oncology actionable, accessible, and affordable.
We aim to improve patient outcomes by providing non-invasive, real-time diagnostic solutions that support early detection, personalized therapy, and continuous monitoring.
A world where cancer care is driven by data, guided by technology, and tailored to each individual patient at the molecular level.
We envision a future where every patient receives timely, personalized care informed by science and powered by AI — eliminating uncertainty and unlocking better outcomes.
We operate at the unique intersection of:
This integrated approach allows us to deliver deeper, more precise insights—enabling clinicians and researchers to make informed decisions faster and more confidently.
At our core
Developing cutting-edge solutions for unmet patient needs.
Delivering care that respects individual patient needs.
Upholding our values with authenticity.
Adapting to evolving medical and technological landscapes.
Partnering with stakeholders to enhance patient outcomes.
Transforming Oncology Through Science and Technology
At 1Cell.Ai, we are committed to delivering real-world change in how cancer is detected, monitored, and treated. Through the power of AI, single cell genomics, and integrated bioinformatics, our solutions have already improved patient care, advanced research, and accelerated targeted drug development. Our impact is measured not just in numbers—but in lives touched and possibilities unlocked.
First to introduce live CTC-based single-cell diagnostics to market.
Thousands of patients served through our AI-powered precision oncology platform.
Trusted by leading hospitals, research institutions, and biopharma partners globally.
Advancing the frontier of multi-omics, AI, and digital pathology to shape the future of cancer care.
Strategic Partnerships to provide the best-in-class. Our prominent partners from both academia and industries:
For partnership and product enquiries please reach out us. Click here.
Whether you’re a clinician, researcher, or industry partner, we’re ready to work with you to advance the future of precision oncology and translational research
